KYLYS is pleased to announce that its main patent application filed under the PCT convention recently entered the national phases. This is an important step toward protecting KYLYS’s invention in multiple countries worldwide.
Read More
We are very proud to have been selected by the BioInnovation Day 2018 organization to present our project HA Pearls. The 8th edition of BioInnovation Day took place on 15 November 2018 at Geneva’s Life Sciences Hub Campus Biotech, providing an opportunity for researchers, scientist-entrepreneurs and early-stage start-up ventures to pitch their projects to an audience of peers, investors, and industry representatives....
Read More
KYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible molecule found throughout the body that is a vital component of healthy joint and tissue...
Read More
We have presented our technology to a prestigious international meeting: the 44th Annual Meeting & Exposition of the Controlled Release Society in Boston, Massachusetts, United...
Read More
We have presented our technology to the most important world hyaluronan conference in Cleveland, Ohio, United States.
Read More
We have presented our experience “from researcher to entrepreneur” to a packed audience at the Centre Médical Universitaire on Tuesday, 2nd of May 2017, Geneva. This event was organized by UNITEC...
Read More